| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00330-017-4751-X |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00330-017-4751-x |
| P698 | PubMed publication ID | 28168370 |
| P2093 | author name string | Yi Cui | |
| Hiroki Shirato | |||
| Jia Wu | |||
| Ruijiang Li | |||
| Khin Khin Tha | |||
| Shangjie Ren | |||
| P2860 | cites work | Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme | Q21135142 |
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Quantitative imaging in cancer evolution and ecology | Q27016021 | ||
| The UCSC Cancer Genomics Browser | Q28239848 | ||
| Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 | ||
| Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 | ||
| CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. | Q30373363 | ||
| MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. | Q30413586 | ||
| Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers | Q30414111 | ||
| Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme. | Q30571373 | ||
| Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging | Q30649180 | ||
| Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. | Q30668767 | ||
| Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. | Q30810422 | ||
| Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features | Q30820677 | ||
| Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set. | Q30885589 | ||
| Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. | Q30914733 | ||
| Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI | Q30938479 | ||
| Apparent Diffusion Coefficient Value Is Not Dependent on Magnetic Resonance Systems and Field Strength Under Fixed Imaging Parameters in Brain | Q30960096 | ||
| Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images | Q30992145 | ||
| Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma | Q31086005 | ||
| Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis | Q33260013 | ||
| Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging | Q33525779 | ||
| Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality | Q33933592 | ||
| Robust Radiomics feature quantification using semiautomatic volumetric segmentation | Q35206996 | ||
| The UCSC Cancer Genomics Browser: update 2015 | Q35253526 | ||
| Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival | Q35707516 | ||
| Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial | Q35815291 | ||
| Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability | Q35945509 | ||
| Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging | Q36048224 | ||
| Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. | Q36618214 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients. | Q36785131 | ||
| Current clinical development of PI3K pathway inhibitors in glioblastoma | Q38012438 | ||
| Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging | Q38471533 | ||
| Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features | Q39382110 | ||
| Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials | Q39435280 | ||
| Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma | Q39685607 | ||
| Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. | Q40721144 | ||
| Diffusion-weighted MR imaging and MGMT methylation status in glioblastoma: a reappraisal of the role of preoperative quantitative ADC measurements | Q43071200 | ||
| elastix: a toolbox for intensity-based medical image registration | Q43583315 | ||
| A multi-center study: intra-scan and inter-scan variability of diffusion spectrum imaging. | Q44493448 | ||
| Correcting eddy current and motion effects by affine whole-brain registrations: evaluation of three-dimensional distortions and comparison with slicewise correction. | Q45873327 | ||
| Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. | Q45918451 | ||
| Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. | Q46118866 | ||
| Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. | Q48416095 | ||
| Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. | Q48582092 | ||
| Predicting survival in glioblastomas using diffusion tensor imaging metrics. | Q55463817 | ||
| Kernel density estimation via diffusion | Q57308724 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3583-3592 | |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma | |
| P478 | volume | 27 |
| Q93154492 | 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
| Q92924304 | A three-dimensional computational analysis of magnetic resonance images characterizes the biological aggressiveness in malignant brain tumours |
| Q90498197 | An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning |
| Q64099174 | Decoding the Interdependence of Multiparametric Magnetic Resonance Imaging to Reveal Patient Subgroups Correlated with Survivals |
| Q62491651 | Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III-IV lung squamous cell carcinoma |
| Q90016852 | Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study |
| Q92686487 | Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups |
| Q57462580 | Morphological MRI-based features provide pretreatment survival prediction in glioblastoma |
| Q52643306 | Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study. |
| Q89145868 | Prediction of survival with multi-scale radiomic analysis in glioblastoma patients |
| Q64052923 | Prognostic models based on imaging findings in glioblastoma: Human versus Machine |
| Q33624662 | Radiogenomic Analysis of Oncological Data: A Technical Survey |
| Q58099090 | Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis |
| Q47701839 | Radiomics and radiogenomics for precision radiotherapy |
| Q64994466 | Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation. |
Search more.